Table 1.
NetLogo applications in immune system modeling.
| Modeling innate immunity | |
| Spatially configured stochastic reaction chambers (SCSRC) | [24] |
| Agent-based model of inflammation and fibrosis | [25] |
| Agent-based multiscale modular architecture for dynamic representation of acute inflammation | [26] |
| Agent-based modeling of endotoxin-induced acute inflammatory response in human blood leukocytes | [27] |
| Modeling immunity to pathogens | |
| Control of human papillomavirus | [28] |
| Model of human papillomavirus type 16 | [29] |
| Intercellular peptide transfer through gap junctions | [30] |
| Connexin hemichannels enter the signalling limelight | [31] |
| Antigen transport and firebreaks In immune responses | [32] |
| Modeling immune system dynamic | |
| Mathematical epidemiology of infectious diseases | [33] |
| Heterogeneity in infection-exposure history and immunity of a protozoan parasite | [34] |
| Multicell agent-based simulation of the microvasculature | [35] |
| Modeling diseases | |
| Immunology of multiple sclerosis | [36] |
| Agent-based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis | [37] |
| Molecular bases of virulence of Candida albicans, Cryptococcus neoformans, and Aspergillus fumigates | [38] |
| Agent-based modeling approach of immune defense against spores of opportunistic human pathogenic fungi | [39] |
| Tumor immunology | |
| Mathematical and computational models in tumor immunology | [40] |
| An agent-based model of solid tumor progression | [41] |